VANCOUVER, Aug. 31, 2017 /Weed Wire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
Tag Archives: ACBFF
Aurora Completes Acquisition of Peloton Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 4, 2017 /Weed Wire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that, further to its press release of March 6, 2017, the Company has completed the acquisition of Peloton Pharmaceuticals Inc. (“Peloton”), a Montreal-area late-stage ACMPR-applicant.
Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO
VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.
Aurora Cannabis Appoints Neil Belot Chief Global Business Development Officer
VANCOUVER, British Columbia, March 21, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that Neil Belot has been promoted to Chief Global Business Development Officer.
Aurora to Acquire Peloton Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 6, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its proposal (the “Proposal”) to acquire Peloton Pharmaceuticals Inc. out of bankruptcy protection was approved by Peloton’s creditors at a recent meeting (the “Creditor Meeting”).
Aurora Cannabis Expands E-commerce Strategy With Launch of Second Generation Mobile App
VANCOUVER, British Columbia, March 1, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today unveiled the second generation of its popular mobile application, incorporating a number of enhanced features to provide a significantly upgraded user experience to new and existing clients of the Company.
Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration Arrangements
VANCOUVER, British Columbia, Feb. 13, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies (“Radient”) (TSXV: RTI) are pleased to provide an update on their previously announced collaboration arrangements.
Aurora Receives Health Canada License to Sell Cannabis Oils
VANCOUVER, British Columbia, Jan. 23, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on January 20, 2017, its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., a licensed producer and distributor of medical cannabis, was licensed by Health Canada for the sale of cannabis oils.
Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales
VANCOUVER, British Columbia, Jan. 16, 2017 /Weed Wire/ — Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
Aurora Appoints Cam Battley Executive Vice President
VANCOUVER, Nov. 7, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that Cam Battley has been appointed Executive Vice President.
Aurora Announces Conversion of $15 Million Debentures
VANCOUVER, British Columbia, Oct. 20, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has elected to exercise its right under the indenture (the “Indenture”) governing the Company’s 10.0% unsecured convertible debentures.
Aurora Cannabis Announces Up to $25 Million Private Placement of Convertible Debentures
VANCOUVER, Oct. 11, 2016 /Weed Wire/ — Aurora Cannabis Inc. announced today that it has entered into an agreement with a syndicate of agents led by Canaccord Genuity Corp.
Aurora Appoints Joseph del Moral to Board of Directors
VANCOUVER, Oct. 6, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora” or the “Issuer”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that Mr. Joseph del Moral has been appointed to the Company’s Board of Directors.
Aurora Completes $15 Million Debenture Offering, Improves Balance Sheet by Replacing High Interest Secured Debt
VANCOUVER, British Columbia, Sept. 28, 2016/Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (CSE: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce, further to its news release dated September 16, 2016, that it has completed the brokered private placement.
Operational Update: Aurora Cannabis Exceeds 7,700 Registered Patients, Continues Rapid Sales Growth
VANCOUVER, Sept. 6, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB) (FRANKFURT: 21P) (WKN: A1C4WM) (OTCQB: ACBFF) (“Aurora” or the “Company”) is pleased to provide the following operational update.
Aurora Cannabis to Acquire CanvasRx, Closes $23 Million Financing, Monthly Gross Revenue Surpasses $1 Million - Video Available on Investmentpitch.com
VANCOUVER, Aug. 12, 2016 /Weed Wire/ — Aurora Cannabis (CSE: ACB) (OTCQB: ACBFF) (FSE: 21P), has entered into a definitive agreement to acquire CanvasRx Inc. from CanvasRx Holdings Inc.
Aurora Cannabis Closes $23 Million Financing and Signs Definitive Agreement to Acquire CanvasRx
VANCOUVER, Aug. 10, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (CSE: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has entered into a definitive share purchase agreement with CanvasRx Holdings Inc. to acquire (the “Acquisition”) all of the issued and outstanding shares of CanvasRx Inc.
Aurora Announces Management Change
VANCOUVER, Aug. 8, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE: ACB) (FRANKFURT: 21P) (WKN: A1C4WM) (OTCQB: ACBFF) (“Aurora” or the “Company”) announced that CFO John Bean will be leaving the company to pursue other career interests.
Aurora Announces Terms and Increase of Brokered Private Placement to $18 Million
VANCOUVER, British Columbia, July 18, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE: ACB) (OTCQB: ACBFF) is pleased to announce, further to its news release dated June 8, 2016, the pricing terms, and an increase in the size of its best efforts private placement offering of subscription receipts.
Aurora to Acquire CanvasRx, Uniting One of the Fastest Growing Cannabis Producers and Canada’s Largest Cannabis Patient Counselling Service
VANCOUVER, June 8, 2016 /Weed Wire/ — Aurora Cannabis Inc. – (the “Company” or “Aurora”) (CSE: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has entered into a letter of intent (the “LOI”) to acquire (the “Acquisition”) all of the issued and outstanding shares of CanvasRx Inc. (“CanvasRx”).
Aurora Enters Into $5 Million Equity Facility With New York Private Equity Firm Alumina Partners LLC
VANCOUVER, June 6, 2016 /Weed Wire/ — Aurora Cannabis Inc. – (the “Company” or “Aurora”) (CSE – “ACB”) (OTCQB – “ACBFF”) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on June 3, 2016, the Company entered into a non-binding agreement for a draw-down equity facility of up to $5,000,0000.
Aurora Announces Q3 2016 Results
VANCOUVER, British Columbia, May 30, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(WKN:A1C4WM)(OTCQB:ACBFF) (“Aurora” or the “Company”) announced its financial and operational results for the three and nine month periods ended March 31, 2016. Aurora is a Licensed Producer of medical cannabis under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).
Aurora Cannabis Exceeds 3,000 Active Registered Patients in Five Months
VANCOUVER, British Columbia, May 30, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB) (FRANKFURT:21P) (WKN:A1C4WM) (OTCQB:ACBFF) (“Aurora” or the “Company”), announced that the Company has exceeded 3,000 active registered patients over the first five months since commencement of product sales on January 5, 2016.
Aurora Launches Same-Day Medical Marijuana Delivery in Calgary
VANCOUVER, British Columbia, May 24, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT: 21P)(OTCQB: ACBFF)(WKN: A1C4WM) (“Aurora” or the “Company”), is pleased to announce that the Company has launched same-day delivery of medical cannabis orders to registered customers in Calgary and surrounding communities, an area encompassing a population of 1.2 million people.
Aurora Cannabis Surpasses 2,000 Registered Patients in Four Months
VANCOUVER, British Columbia, May 9, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(OTCQB:ACBFF) (WKN:A1C4WM) announced that the Company has surpassed 2,000 registered patients over its first four months of product sales.